Abstract:Objective To summarize the current situation, management and prognosis of adverse drug reactions (ADRs) of azathioprine (AZA) in treating patients suffered from inflammatory bowel disease (IBD). Methods A retrospective analysis was conducted based on the data of 364 IBD patients, including 292 cases of Crohn′s disease and 72 cases of ulcerative colitis, who were treated with AZA from December 1994 to September 2015 at Sir Run Run Shaw Hospital. Results Among the 364 patients with inflammatory bowel disease, a total of 178 adverse events were observed in 147 patients (40.4% of all the patients), including myelotoxicity in 74 cases, hepatic dysfunction in 31 cases, gastrointestinal reaction in 18 cases, infection in 14 cases, arthralgia in 11 cases, besides, other 30 adverse events included pancreatitis, dizziness, headache, tetter, alopecia, fever and so on. 42.1% (75/178) of adverse events occurred within the first month of therapy. 20.1% of patients (73/364) stopped the administration because of the side effects, and among them, 52.1% (38/73) of patients stopped in the first month of therapy. All the adverse reactions could be self-recovered or recovered under proper treatment. There were no irreversible and fatal cases in this study. Conclusions Rates of adverse reactions and drug-withdraw in IBD patients treated by AZA are quite high. The clinical manifestations of ADRs are varied, usually in myelotoxicity and abnormal liver function. Close attention should be paid to the ADRs caused by AZA, especially at the beginning of therapy. ADRs about special infections, pancreatitis and agranulocytosis are rare. AZA is relatively safe. Key words: Ulcerative colitis; Crohn′s disease; Azathioprine; Adverse reaction

Analysis on 198 cases adverse drug reaction/event reports of azithromycin

Analysis and Prevention of Liver Injury Caused by Azithromycin:a Retrospective Study of 27 Cases

Analysis on 522 cases of antibacterial-related adverse drug reaction/event reports

Analysis on 428 Cases Adverse Drug Reaction/event Reports of Antibacterial Agents

Analysis of 84 Cases of Adverse Reactions Induced by Voriconazole

Analysis of the Adverse Drug Reactions Reports of 139 Cases

Analysis on 342 Repors and Discssion about the Methods of Prevention with Adverse Drug Reactions/events

Adverse Drug Reactions Induced by Gatifloxacin:Analysis of 866 Cases During 2003～2006

Analysis of 145 ADR Reports of Children in Our Hospital in 2010

Safety of azithromycin in pediatrics: a systematic review and meta-analysis

Analysis of Adverse Drug Reactions of Azathioprine in the Treatment of Patients with Inflammatory Bowel Disease

Analysis of 187 Cases of Adverse Reactions Caused by Anti-Infection Drugs in Our Hospital

The Analysis of 288 Cases Adverse Drug Reaction Caused by Antibacterial drugs

Adverse Drug Reactions Induced by Anti-infectives:Analysis of 657 Cases

Adverse events associated with azithromycin and clarithromycin in adults aged ≥65: a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database

The Efficacy and Safety of Azithromycin in Asthma: A Systematic Review

Analysis of 114 Severe ADR Cases Induced by Antibacterial Drugs in Our Hospital

Safety profiles and adverse reactions of azithromycin in the treatment of pediatric respiratory diseases: A systematic review and meta-analysis

A Randomized Controlled Clinical Trial on Injective Azithromycin Versus Erythromycin in the Treatment of Respiratory Tract Bacterial Infections.

Analysis on Adverse Drug Reactions in Our Hospital from 2008 to 2010

Clinical evaluation of azithromycin